New Key Statistics Module, Z-Score and F-Score
NYSE:CRL Key Ratios
| Market Cap $ M | 11,708.14 |
| Enterprise Value $ M | 14,521.97 |
| P/E(ttm) | 24.63 |
| PE Ratio without NRI | 20.55 |
| Forward PE Ratio | 20.78 |
| Price/Book | 3.24 |
| Price/Sales | 2.80 |
| Price/Free Cash Flow | 32.02 |
| Price/Owner Earnings | 25.80 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 4,129.00 |
| EPS (TTM) $ | 9.23 |
| Beneish M-Score | -2.6 |
| 10-y EBITDA Growth Rate % | 15.20 |
| 5-y EBITDA Growth Rate % | 15.20 |
| y-y EBITDA Growth Rate % | 4.40 |
| EV-to-EBIT | 20.23 |
| EV-to-EBITDA | 14.07 |
| PEG | 1.35 |
| Shares Outstanding M | 51.51 |
| Net Margin (%) | 11.49 |
| Operating Margin % | 14.95 |
| Pre-tax Margin (%) | 14.08 |
| Quick Ratio | 1.16 |
| Current Ratio | 1.52 |
| ROA % (ttm) | 6.10 |
| ROE % (ttm) | 14.61 |
| ROIC % (ttm) | 7.12 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.75 |
| Piotroski F-Score | 6.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
CRL Number of Guru Trades
CRL Volume of Guru Trades
Gurus Latest Trades with NYSE:CRL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:CRL is held by these investors
Total 3
Charles River Laboratories International Inc Insider Transactions
No Available Data
News about NYSE:CRL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers